Group by:
Date |
Item TypeArticle
The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts.
Behrens, D., Lykkesfeldt, A.E. and Fichtner, I.
Targeted Oncology 2
(3): 135-144.
July 2007
Review
The role of biologics in stomach cancer.
Lordick, F., Schulze, T. and Jaeger, D.
Targeted Oncology 3
(2): 71-79.
April 2008
This list was generated on Wed Nov 13 17:08:42 2024 UTC.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
